Back to results
US 2014/0348832 A1Published application
Inhibitors of t-cell activation
AssigneeGenzyme Corporation
InventorsYunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng
Life of this patent
Estimating the term…
Abstract
The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
Claims21
1-16. (canceled)
A bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
Dependencies are inferred from the claim text.